STRUCTURAL AND FUNCTIONAL FEATURES OF POLYMORPHIC LOCI OF BRCA1 AND BRCA2 GENES IN THE ENDOMETRIAL CANCER

СТРУКТУРНО-ФУНКЦИОНАЛЬНЫЕ ОСОБЕННОСТИ ПОЛИМОРФНЫХ ЛОКУСОВ ГЕНОВ BRCA1 И BRCA2 ПРИ РАКЕ ЭНДОМЕТРИЯ
Ж. К. Чингисова
More Detail
J CLIN MED KAZ, Volume 3, Issue 29, pp. 47-50.
OPEN ACCESS 2267 Views 2104 Downloads
Download Full Text (PDF)

ABSTRACT

The researches dedicate to search the structuralfunctional futures of genomes for prognosis of effectiveness of treatment endometrial cancer by conducting with molecular-genetic methods/ In result the work we detected of BRCA1 gene polymorphism at codon 356, 502, 1655 are representative based polymorphism and could perform as effectiveness genetic marker in determine of predisposition risk of tumor genesis in population-family history of diseases.
The presence 4553delA, 2683TTGAT of BRCA1 gene may correspond to different degrees of histological malignancy.

CITATION

Чингисова ЖК. STRUCTURAL AND FUNCTIONAL FEATURES OF POLYMORPHIC LOCI OF BRCA1 AND BRCA2 GENES IN THE ENDOMETRIAL CANCER. Journal of Clinical Medicine of Kazakhstan. 2013;3(29):47-50.

REFERENCES

  • G.Ursin, B.E.Henderson, R.W.Haile e.a. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? // Cancer Res.- 1997.- V. 57, N 17.- P. 3678 - 3681.
  • Б.П.Копнин Мишени действия онкогенов и опухолевых супрессоров: ключ к пониманию базовых механизмов канцерогенеза // Биохимия. – 2000. - № 65. – С.5-33.
  • Y Miki, J Swensen, D Shattuck-Eidens, Futreal, PA Harshman, K S Tavtigian, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
  • R.Wooster, G.Bignell, J.Lancaster et all. Identifi cation of the breast cancer susceptibility gene BRCA2 // Nature. -2007.-№ 378.- Р.789-792.
  • L.Zheng, S.Li, T.G.Boyer, W.H.Lee Lesons learned from BRCA1 and BRCA2 // Oncogene. – 2000. – Vol. 19. –P 6159-6175.
  • Elizabeth M.Rohlefs, William G. Learning, Kenneth J. Friedman, Fergus J. Couch, Barbara L.Weber,et al. Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis Clinical Chemistry 43:1 24-29 (1997).